Garden State Investment Advisory Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-589
Closed -$207K – 368
2026
Q1
$207K Sell
589
-100
-15% -$35.6K 0.05% 285
2025
Q4
$226K Buy
+689
New +$219K 0.05% 276
2025
Q2
– Sell
-837
Closed -$261K – 309
2025
Q1
$261K Buy
837
+15
+2% +$4.43K 0.08% 201
2024
Q4
$214K Buy
822
+79
+11% +$23.4K 0.06% 226
2024
Q3
$239K Sell
743
-1
-0.1% -$327 0.08% 194
2024
Q2
$232K Buy
744
+10
+1% +$2.94K 0.08% 195
2024
Q1
$208K Hold
734
– – 0.08% 206
2023
Q4
$211K Buy
+734
New +$200K 0.08% 195

Other funds holding AMGN

Garden State Investment Advisory Services's AMGN Position: Q2 2026 in Review

Garden State Investment Advisory Services sold out of Amgen (AMGN) in Q2 2026, closing a stake of 589 shares — an estimated $207K sold.

Garden State Investment Advisory Services first reported a position in AMGN in Q4 2023 and held it in 8 quarters. The position peaked at $261K in Q1 2025. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Garden State Investment Advisory Services reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • Garden State Investment Advisory Services sold 589 Amgen shares in Q2 2026, an estimated $207K.
  • Garden State Investment Advisory Services first reported a position in Amgen in Q4 2023 and held it in 8 quarters.
  • Garden State Investment Advisory Services's Amgen position peaked at $261K in Q1 2025.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Garden State Investment Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.